RI
MIST icon

RTW Investments’s Milestone Pharmaceuticals MIST Stock Holding History

RTW Investments’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.53M Buy
6,331,001
+3,824,899
+153% +$6.7M 0.08% 73
2025
Q4 		$5.06M Hold
2,506,102
– – 0.05% 79
2025
Q3 		$5.01M Hold
2,506,102
– – 0.06% 69
2025
Q2 		$4.86M Hold
2,506,102
– – 0.07% 66
2025
Q1 		$2.01M Hold
2,506,102
– – 0.03% 65
2024
Q4 		$5.91M Sell
2,506,102
-750,000
-23% -$1.29M 0.09% 59
2024
Q3 		$4.95M Hold
3,256,102
– – 0.07% 58
2024
Q2 		$4.3M Hold
3,256,102
– – 0.07% 58
2024
Q1 		$5.83M Hold
3,256,102
– – 0.09% 60
2023
Q4 		$5.44M Hold
3,256,102
– – 0.08% 58
2023
Q3 		$10.1M Hold
3,256,102
– – 0.21% 46
2023
Q2 		$9.28M Hold
3,256,102
– – 0.18% 51
2023
Q1 		$12.8M Sell
3,256,102
-1,059,000
-25% -$3.87M 0.27% 40
2022
Q4 		$17.1M Hold
4,315,102
– – 0.35% 40
2022
Q3 		$39.7M Hold
4,315,102
– – 0.91% 32
2022
Q2 		$26.5M Hold
4,315,102
– – 0.69% 35
2022
Q1 		$27.7M Hold
4,315,102
– – 0.57% 45
2021
Q4 		$28.3M Hold
4,315,102
– – 0.41% 57
2021
Q3 		$24.6M Hold
4,315,102
– – 0.37% 56
2021
Q2 		$23.7M Hold
4,315,102
– – 0.36% 55
2021
Q1 		$25M Hold
4,315,102
– – 0.39% 57
2020
Q4 		$28.9M Hold
4,315,102
– – 0.49% 48
2020
Q3 		$31.6M Hold
4,315,102
– – 0.76% 37
2020
Q2 		$16.3M Hold
4,315,102
– – 0.46% 45
2020
Q1 		$7.94M Buy
4,315,102
+356,838
+9% +$6.18M 0.34% 48
2019
Q4 		$63.4M Buy
3,958,264
+436,408
+12% +$7.72M 2.39% 14
2019
Q3 		$63.8M Hold
3,521,856
– – 3.8% 7
2019
Q2 		$91M Buy
+3,521,856
New +$72.6M 4.86% 7

Other funds holding MIST

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

RTW Investments's MIST Position: Q1 2026 in Review

RTW Investments increased its Milestone Pharmaceuticals (MIST) stake by 153% in Q1 2026, buying an estimated $6.7M and bringing the position to 6,331,001 shares worth $7.53M. The position accounts for 0.08% of the portfolio, ranked #73.

RTW Investments first reported a position in MIST in Q2 2019 and has held it in 28 quarters since. The position peaked at $91M in Q2 2019. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • RTW Investments held 6,331,001 shares of Milestone Pharmaceuticals worth $7.53M as of Q1 2026.
  • RTW Investments bought 3,824,899 Milestone Pharmaceuticals shares in Q1 2026, an estimated $6.7M.
  • Milestone Pharmaceuticals made up 0.08% of RTW Investments's portfolio in Q1 2026, its #73 holding.
  • RTW Investments first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 28 quarters since.
  • RTW Investments's Milestone Pharmaceuticals position peaked at $91M in Q2 2019.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on RTW Investments's 13F filing for Q1 2026, filed 15 May 2026.